Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries ...
Sep 11, 2019
0
2
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act ...
Jun 6, 2013
0
0
President Joe Biden signed an executive order Sept. 12 to launch a National Biotechnology and Biomanufacturing Initiative, noting the United States relies too heavily on foreign materials and foreign bioproduction. Offshoring ...
Oct 3, 2022
0
4
South Africa's government has published a draft intellectual property policy with potential far-reaching effects for pharmaceutical patents, which rights groups hailed Monday as a move towards lower medicine costs.
Sep 9, 2013
0
0
Shares in Indian generic drugs giant Ranbaxy Laboratories crashed by as much as 35 percent on Monday after the US Food and Drug Administration suspended imports from one of its factories.
Sep 16, 2013
0
0
It is not proven that patients with wet age-related macular degeneration benefit from the new drug aflibercept, as the drug manufacturer did not present any suitable data for a comparison with the current standard therapy ...
Jun 5, 2013
0
0
A combination of factors including the current corporate tax rate makes pharmaceutical production in the United States more attractive now than investing in either China or India. And adopting advanced technologies such as ...
Sep 30, 2021
0
2
Clinical drug trials are a vital part of pharmaceutical manufacturers gaining approval for use by the U.S. Food and Drug Administration. A Commentary scheduled for publication in The Journal of Pediatrics assesses the issues ...
Oct 25, 2012
0
0
India's Health Ministry said Friday it had set up an expert panel to review the operations of its drug regulatory agency, accused of colluding with pharmaceutical firms to approve drugs without trials.
May 11, 2012
0
0
Past public ire over high drug prices has recently taken a back seat to a more insidious problem—no drugs at any price.
Jul 20, 2023
0
0
